Dhananjay Tikariha
Fund manager Dhananjay Tikariha: portfolio changes across the 1 scheme AMFI's scheme summary documents name them on, Oct 2026, by share count.
Equity.
1 with AMFI average AUM, July - September 2026; each scheme in full, not split between co-managers. Source: AMFI.
On a scheme named on today, as the fund house files it. Source: AMFI SSD.
People named on at least one of the same schemes.
| Scheme | Fund house | Category | AUM | Role, as filed | Since, as filed | As of |
|---|---|---|---|---|---|---|
| Kotak Healthcare Fund | Kotak Mahindra Mutual Fund | Equity Scheme - Sectoral/ Thematic | ₹743 cr | — | — | 2 Nov 2026 |
From each scheme's summary document on AMFI's site (scheme details), as it stood on the date shown. How to read
Named on the same scheme's summary document; the number is how many schemes they share. Source: AMFI SSD.
- ₹116 cr
- ₹88.0 cr
- ₹42.0 cr
- ₹40.8 cr
- ₹36.9 cr
- ₹36.1 cr
- ₹30.1 cr
- ₹27.9 cr
- ₹27.9 cr
- ₹27.6 cr
| Ticker | Company | Value | % of equity held | Schemes holding |
|---|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹116 cr | 13.6 % | 1 |
| DIVISLAB | Divi's Laboratories Limited | ₹88.0 cr | 10.3 % | 1 |
| ACUTAAS | Acutaas Chemicals Limited | ₹42.0 cr | 4.9 % | 1 |
| MOLBIO | Molbio Diagnostics Limited | ₹40.8 cr | 4.8 % | 1 |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹36.9 cr | 4.3 % | 1 |
| LAURUSLABS | Laurus Labs Limited | ₹36.1 cr | 4.2 % | 1 |
| MAXHEALTH | Max Healthcare Institute Limited | ₹30.1 cr | 3.5 % | 1 |
| APOLLOHOSP | Apollo Hospitals Enterprise Limited | ₹27.9 cr | 3.3 % | 1 |
| GLAND | Gland Pharma Limited | ₹27.9 cr | 3.3 % | 1 |
| CIPLA | Cipla Limited | ₹27.6 cr | 3.2 % | 1 |
| SAILIFE | Sai Life Sciences Limited | ₹24.9 cr | 2.9 % | 1 |
| YATHARTH | Yatharth Hospital & Trauma Care Serv Ltd | ₹23.1 cr | 2.7 % | 1 |
| MANKIND | Mankind Pharma Limited | ₹22.4 cr | 2.6 % | 1 |
| FORTIS | Fortis Healthcare Limited | ₹21.5 cr | 2.5 % | 1 |
| PRASOLCHEM | PRASOL CHEMICALS LTD | ₹21.3 cr | 2.5 % | 1 |
The 15 largest holdings by market value, summed over the schemes this manager is named on today.
1 scheme has no filed start date, so no return is shown
Each scheme's direct-growth return over the dates filed for this manager, next to its category's average. Returns and averages are computed by this site from AMFI NAVs; they are not the fund house's figures. Past performance may not be sustained in future.
| Month | Schemes with a change | Stocks added | Stocks cut | Bought | Sold | Net |
|---|---|---|---|---|---|---|
| Oct 2026 | 1 | 10 | 2 | ₹60.0 cr | ₹16.6 cr | +₹43.4 cr |
| Sep 2026 | 1 | 16 | 1 | ₹67.7 cr | ₹1.3 cr | +₹66.4 cr |
| Aug 2026 | 1 | 7 | 2 | ₹78.6 cr | ₹7.8 cr | +₹70.8 cr |
| Jul 2026 | 1 | 7 | 14 | ₹75.3 cr | ₹88.8 cr | −₹13.5 cr |
| Jun 2026 | 1 | 21 | 0 | ₹79.3 cr | ₹0.00 cr | +₹79.3 cr |
| May 2026 | 1 | 9 | 2 | ₹34.2 cr | ₹3.3 cr | +₹30.9 cr |
| Apr 2026 | 1 | 7 | 6 | ₹30.7 cr | ₹11.8 cr | +₹19.0 cr |
| Mar 2026 | 1 | 0 | 18 | ₹0.00 cr | ₹19.7 cr | −₹19.7 cr |
| Jan 2026 | 1 | 4 | 2 | ₹16.8 cr | ₹7.2 cr | +₹9.5 cr |
| Dec 2025 | 1 | 2 | 9 | ₹20.0 cr | ₹33.0 cr | −₹13.0 cr |
Across the schemes this manager is named on today, by share count.
Changes seen in AMFI's documents
since 29 Sep 2026
Changes on this manager's schemes, by the date AMFI's document first showed them.
Added 10
10 stocks · largest 10 by value
| Stock | Schemes | Implied change, share count × price | Price 30 Oct 2026, 12‑month change |
|---|---|---|---|
| PARASHLTH | 1 | +₹17.0 cr | — |
| SUNPHARMA | 1 | +₹8.9 cr | ₹1,777.70 ▲ +5.1% |
| LAURUSLABS | 1 | +₹7.2 cr | ₹2,405.50 ▲ +152.2% |
| DIVISLAB | 1 | +₹6.8 cr | ₹9,780.00 ▲ +45.1% |
| ZYDUSLIFE | 1 | +₹6.2 cr | ₹1,245.50 ▲ +27.8% |
| PRASOLCHEM | 1 | +₹3.6 cr | ₹805.10 ▼ −4.1% |
| METROPOLIS | 1 | +₹2.7 cr | ₹545.65 ▲ +10.8% |
| MAXHEALTH | 1 | +₹2.6 cr | ₹860.00 ▼ −25.1% |
| APOLLOHOSP | 1 | +₹2.5 cr | ₹8,448.00 ▲ +10.0% |
| FORTIS | 1 | +₹2.3 cr | ₹768.15 ▼ −24.9% |
Each scheme's change in shares at its month-end price, summed over this manager's schemes, Oct 2026.
Questions about Dhananjay Tikariha
from the figures on this pageWhat stocks are in Dhananjay Tikariha's portfolio?
The 1 scheme Dhananjay Tikariha manages held 34 stocks worth ₹852 cr at Oct 2026 end. Largest: Sun Pharmaceutical Industries 13.6 %, Divi's Laboratories 10.3 %, Acutaas Chemicals 4.9 %, Molbio Diagnostics 4.8 %, Torrent Pharmaceuticals 4.3 %. Sun Pharmaceutical Industries mutual fund holdings · Divi's Laboratories mutual fund holdings · Acutaas Chemicals mutual fund holdings
Which stocks did Dhananjay Tikariha buy and sell in Oct 2026?
In Oct 2026, Dhananjay Tikariha's schemes added to 10 stocks, largest Paras Healthcare (PARASHLTH), Sun Pharmaceutical Industries (SUNPHARMA), Laurus Labs (LAURUSLABS); cut 2, largest Rainbow Childrens Medicare (RAINBOW), Pfizer (PFIZER), by value at month-end prices.
Which mutual fund schemes does Dhananjay Tikariha manage?
AMFI's scheme summary documents name Dhananjay Tikariha (Kotak Mahindra Mutual Fund) for 1 scheme: Kotak Healthcare Fund. Kotak Healthcare Fund portfolio